Wim Wynendaele

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

Ferry A.L.M. Eskens, Herlinde Dumez, Ronald Hoekstra et al. · European Journal of Cancer · 2003 · 222 citations

Oncology, Pharmacology, Advanced Solid Tumours +7

Cancer and renal insufficiency results of the BIRMA study

Nicolas Janus, Vincent Launay‐Vacher, E. Byloos et al. · British Journal of Cancer · 2010 · 190 citations · Full text

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?

Wim Wynendaele, Rita Derua, Marc Hoylaerts et al. · Annals of Oncology · 1999 · 114 citations

Thrombopoiesis, Thrombosis, Angiogenesis +15

A real-time quantitative reverse transcriptase polymerase chain reaction (RT–PCR) to detect breast carcinoma cells in peripheral blood

Joeri L. Aerts, Wim Wynendaele, Robert Paridaens et al. · Annals of Oncology · 2001 · 84 citations · Full text

Polymerase Chain Reaction, Breast Oncology, Oncology +13

Vascular targeting of solid tumours

Willy Landuyt, O Verdoes, D.O Darius et al. · European Journal of Cancer · 2000 · 66 citations · Full text

Angiogenesis, Vascular Targeting, Vascular Biology +6